Related references
Note: Only part of the references are listed.Advances in the clinical management of uveal melanoma
Richard D. Carvajal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Mitochondrial-Targeted Antioxidant MitoQ-Mediated Autophagy: A Novel Strategy for Precise Radiation Protection
Xingting Bao et al.
ANTIOXIDANTS (2023)
Patients presenting with metastases: stage IV uveal melanoma, an international study
Gaurav Garg et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2022)
The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma
Vivian Chua et al.
PIGMENT CELL & MELANOMA RESEARCH (2022)
IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells
Anissa A. Widjaja et al.
ISCIENCE (2022)
LKB1 inactivation modulates chromatin accessibility to drive metastatic progression
Sarah E. Pierce et al.
NATURE CELL BIOLOGY (2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Molecular profiling of driver events in metastatic uveal melanoma
Joakim Karlsson et al.
NATURE COMMUNICATIONS (2020)
Role of Sodium/Calcium Exchangers in Tumors
Barbora Chovancova et al.
BIOMOLECULES (2020)
Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells
Justine Leclerc et al.
ONCOGENE (2019)
Na+/Ca2+ exchangers: Unexploited opportunities for cancer therapy?
Tiago Rodrigues et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution
A. Hunter Shain et al.
CANCER CELL (2018)
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
Mickael Ohanna et al.
GENES & DEVELOPMENT (2018)
Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults
Matthew J. Rossman et al.
HYPERTENSION (2018)
Punctuated evolution of canonical genomic aberrations in uveal melanoma
Matthew G. Field et al.
NATURE COMMUNICATIONS (2018)
Metastatic disease from uveal melanoma: treatment options and future prospects
Richard D. Carvajal et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Focus on cutaneous and uveal melanoma specificities
Charlotte Pandiani et al.
GENES & DEVELOPMENT (2017)
Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression
Giada Dogliotti et al.
NATURE COMMUNICATIONS (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma
Xu Chen et al.
CANCER CELL (2017)
ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma
Jae Hyuk Yoo et al.
CANCER CELL (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
The reverse-mode NCX1 activity inhibitor KB-R7943 promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic flux
Zhou Long et al.
ONCOTARGET (2016)
Calcium and ROS: A mutual interplay
Agnes Goerlach et al.
REDOX BIOLOGY (2015)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
MitoQ a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Peizhong Mao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription
Hei-Man Vincent Tang et al.
RETROVIROLOGY (2013)
Genetic and molecular characterization of uveal melanoma cell lines
K. G. Griewank et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
NCX1 phosphorylation dilemma: a little closer to resolution. Focus on Full-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A
Martin Morad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients
Cecile Laurent et al.
CANCER RESEARCH (2011)
Animal and human studies with the mitochondria-targeted antioxidant MitoQ
Robin A. J. Smith et al.
MITOCHONDRIAL RESEARCH IN TRANSLATIONAL MEDICINE (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Chronic Administration of KB-R7943 Induces Up-regulation of Cardiac NCX1
Lin Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Shana N. Wingo et al.
PLOS ONE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Michael D. Onken et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Immunohistochemical expression of phospho-Akt in uveal melanoma
VS Saraiva et al.
MELANOMA RESEARCH (2005)
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death
MD Onken et al.
CANCER RESEARCH (2004)
Sodium/calcium exchanger (NCX1) macromolecular complex
DH Schulze et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
